Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

The shape of cancer relapse: Topological data analysis predicts recurrence in paediatric acute lymphoblastic leukaemia

View ORCID ProfileSalvador Chulián, View ORCID ProfileBernadette J. Stolz, View ORCID ProfileÁlvaro Martínez-Rubio, View ORCID ProfileCristina Blázquez Goñi, View ORCID ProfileJuan F. Rodríguez Gutiérrez, View ORCID ProfileTeresa Caballero Velázquez, View ORCID ProfileÁgueda Molinos Quintana, View ORCID ProfileManuel Ramírez Orellana, Ana Castillo Robleda, View ORCID ProfileJosé Luis Fuster Soler, View ORCID ProfileAlfredo Minguela Puras, View ORCID ProfileMaría V. Martínez Sánchez, View ORCID ProfileMaría Rosa, View ORCID ProfileVíctor M. Pérez-García, View ORCID ProfileHelen M. Byrne
doi: https://doi.org/10.1101/2021.12.22.21268233
Salvador Chulián
1Department of Mathematics, Universidad de Cádiz, 11510 Puerto Real, Cádiz, Spain
2Biomedical Research and Innovation Institute of Cádiz (INiBICA), Hospital Universitario Puerta del Mar, 11009 Cádiz, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Salvador Chulián
  • For correspondence: salvador.chulian{at}uca.es helen.byrne{at}maths.ox.ac.uk
Bernadette J. Stolz
3Mathematical Institute, University of Oxford, OX2 6GG Oxford, United Kingdom
4Laboratory for Topology and Neuroscience, EPFL, Station 8, 1015 Lausanne, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Bernadette J. Stolz
Álvaro Martínez-Rubio
1Department of Mathematics, Universidad de Cádiz, 11510 Puerto Real, Cádiz, Spain
2Biomedical Research and Innovation Institute of Cádiz (INiBICA), Hospital Universitario Puerta del Mar, 11009 Cádiz, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Álvaro Martínez-Rubio
Cristina Blázquez Goñi
2Biomedical Research and Innovation Institute of Cádiz (INiBICA), Hospital Universitario Puerta del Mar, 11009 Cádiz, Spain
5Department of Paediatric Haematology and Oncology, Hospital de Jerez, 11407 Jerez de la Frontera, Spain
6Department of Haematology, Hospital Universitario Vírgen del Rocío, 41013 Sevilla, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Cristina Blázquez Goñi
Juan F. Rodríguez Gutiérrez
2Biomedical Research and Innovation Institute of Cádiz (INiBICA), Hospital Universitario Puerta del Mar, 11009 Cádiz, Spain
5Department of Paediatric Haematology and Oncology, Hospital de Jerez, 11407 Jerez de la Frontera, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Juan F. Rodríguez Gutiérrez
Teresa Caballero Velázquez
7Department of Haematology, Hospital Universitario Vírgen del Rocío / University of Sevilla, 41013 Sevilla, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Teresa Caballero Velázquez
Águeda Molinos Quintana
6Department of Haematology, Hospital Universitario Vírgen del Rocío, 41013 Sevilla, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Águeda Molinos Quintana
Manuel Ramírez Orellana
8Department of Paediatric Haematology and Oncology, Hospital Infantil Universitario Niño Jesús, Instituto Investigación Sanitaria La Princesa, 28009 Madrid, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Manuel Ramírez Orellana
Ana Castillo Robleda
8Department of Paediatric Haematology and Oncology, Hospital Infantil Universitario Niño Jesús, Instituto Investigación Sanitaria La Princesa, 28009 Madrid, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
José Luis Fuster Soler
9Department of Paediatric Haematology and Oncology, Hospital Clínico Universitario Virgen de la Arrixaca, Instituto Murciano de Investigación Biosanitaria (IMIB), 30120 Murcia, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for José Luis Fuster Soler
Alfredo Minguela Puras
10Immunology Service, Hospital Clínico Universitario Virgen de la Arrixaca, Instituto Murciano de Investigación Biosanitaria (IMIB), 30120 Murcia, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Alfredo Minguela Puras
María V. Martínez Sánchez
10Immunology Service, Hospital Clínico Universitario Virgen de la Arrixaca, Instituto Murciano de Investigación Biosanitaria (IMIB), 30120 Murcia, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for María V. Martínez Sánchez
María Rosa
1Department of Mathematics, Universidad de Cádiz, 11510 Puerto Real, Cádiz, Spain
2Biomedical Research and Innovation Institute of Cádiz (INiBICA), Hospital Universitario Puerta del Mar, 11009 Cádiz, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for María Rosa
Víctor M. Pérez-García
11Department of Mathematics, Mathematical Oncology Laboratory (MOLAB), Universidad de Castilla-La Mancha, 13005 Ciudad Real, Spain
12Instituto de Matemática Aplicada a la Ciencia y la Ingeniería (IMACI), Universidad de Castilla-La Mancha, 13005 Ciudad Real, Spain
13ETSI Industriales, Universidad de Castilla-La Mancha, 13005 Ciudad Real, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Víctor M. Pérez-García
Helen M. Byrne
3Mathematical Institute, University of Oxford, OX2 6GG Oxford, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Helen M. Byrne
  • For correspondence: salvador.chulian{at}uca.es helen.byrne{at}maths.ox.ac.uk
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Although children and adolescents with acute lymphoblastic leukaemia (ALL) have high survival rates, approximately 15-20% of patients relapse. Risk of relapse is routinely estimated at diagnosis by biological factors, including flow cytometry data. This high-dimensional data is typically manually assessed by projecting it onto a subset of biomarkers. Cell density and “empty spaces” in 2D projections of the data, i.e. regions devoid of cells, are then used for qualitative assessment. Here, we use topological data analysis (TDA), which quantifies shapes, including empty spaces, in data, to analyse pre-treatment ALL datasets with known patient outcomes. We combine these fully unsupervised analyses with Machine Learning (ML) to identify significant shape characteristics and demonstrate that they accurately predict risk of relapse, particularly for patients previously classified as ‘low risk’. We independently confirm the predictive power of CD10, CD20, CD38, and CD45 as biomarkers for ALL diagnosis. Based on our analyses, we propose three increasingly detailed prognostic pipelines for analysing flow cytometry data from ALL patients depending on technical and technological availability: 1. Visual inspection of specific biological features in biparametric projections of the data; 2. Computation of quantitative topological descriptors of such projections; 3. A combined analysis, using TDA and ML, in the four-parameter space defined by CD10, CD20, CD38 and CD45. Our analyses readily extend to other haematological malignancies.

Author summary Acute lymphoblastic leukaemia (ALL) is a blood cancer which affects predominantly children and adolescents. Therapy typically fails in approximately 20 % of patients, who suffer from relapse. To determine disease status, clinicians assess cell types, their interactions, as well as deviations from normal behaviour. Flow cytometry (FC) is a method that quantifies the intensity of specific cell markers, giving rise to high-dimensional data. This routinely collected information is then reduced to obtain human-interpretable visualisation for prognosis. Topological Data Analysis (TDA) is a field of mathematics that studies shapes in data, considering isolated data islands and empty spaces between them. We showcase how to use TDA to extract shape characteristics in FC data of relapsing patients. We propose three pipelines, of increasing methodological complexity, to aid clinical decisions for risk stratification in ALL. In combination with Machine Learning, TDA enables high-accuracy predictions of relapse to be made at the time of diagnosis.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This work has been partially supported by the Fundación Española para la Ciencia y la Tecnología (FECYT project PR214), the Asociación Pablo Ugarte (APU, Spain), Junta de Andalucía (Spain) group FQM-201, Junta de Comunidades de Castilla-La Mancha (grant number SBPLY/17/180501/000154), the Programme of Research and Transfer Promotion from the University of Cádiz (grant number EST2020-025), Ministery of Science and Technology, Spain (grant number PID2019-110895RB-I00, funded by MCIN/AEI/10.13039/501100011033). This work was also subsidized by a grant for the research and biomedical innovation in the health sciences within the framework of the Integrated Territorial Initiative (ITI) for the province of Cádiz (grant number ITI-0038-2019). ITI is 80% co-financed by the funds of the FEDER Operational Program of Andalusia 2014-2020 (Council of Health and Families). BJS and HMB aremembers of the Centre for Topological Data Analysis, funded by the EPSRC grant (EP/R018472/1). BJS and HMB are members of the Centre for Topological Data Analysis, funded by the EPSRC grant (EP/R018472/1).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

IRB of Hospital Universitario de Jeréz de la Frontera gave ethical approval for this work. IRB of Hospital Infantil Universitario Niño Jesús gave ethical approval for this work. IRB of Hospital Universitario Vírgen del Rocío gave ethical approval for this work. IRB of Hospital Clínico Universitario Vírgen de la Arrixaca gave ethical approval for this work.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • Introduction has been revised to reformulate the manuscript's motivation. Supplemental files have been updated. New specifications have been included in the Methods Section.

Data Availability

Implementation details, code and processed PH data are freely available on https://github.com/salvadorchulian/shapecancerrelapse. Flow cytometry files are available upon request. These datasets can be provided by the corresponding author, S.C., or H.B., pending scientific review and a completed material transfer agreement. Requests for the datasets should be submitted to: S.C., or H.B.. All other data needed to evaluate the conclusions in the paper are present in the paper and/or the Supplementary Materials.

https://github.com/salvadorchulian/shapecancerrelapse

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted April 20, 2023.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
The shape of cancer relapse: Topological data analysis predicts recurrence in paediatric acute lymphoblastic leukaemia
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
The shape of cancer relapse: Topological data analysis predicts recurrence in paediatric acute lymphoblastic leukaemia
Salvador Chulián, Bernadette J. Stolz, Álvaro Martínez-Rubio, Cristina Blázquez Goñi, Juan F. Rodríguez Gutiérrez, Teresa Caballero Velázquez, Águeda Molinos Quintana, Manuel Ramírez Orellana, Ana Castillo Robleda, José Luis Fuster Soler, Alfredo Minguela Puras, María V. Martínez Sánchez, María Rosa, Víctor M. Pérez-García, Helen M. Byrne
medRxiv 2021.12.22.21268233; doi: https://doi.org/10.1101/2021.12.22.21268233
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
The shape of cancer relapse: Topological data analysis predicts recurrence in paediatric acute lymphoblastic leukaemia
Salvador Chulián, Bernadette J. Stolz, Álvaro Martínez-Rubio, Cristina Blázquez Goñi, Juan F. Rodríguez Gutiérrez, Teresa Caballero Velázquez, Águeda Molinos Quintana, Manuel Ramírez Orellana, Ana Castillo Robleda, José Luis Fuster Soler, Alfredo Minguela Puras, María V. Martínez Sánchez, María Rosa, Víctor M. Pérez-García, Helen M. Byrne
medRxiv 2021.12.22.21268233; doi: https://doi.org/10.1101/2021.12.22.21268233

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Hematology
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)